Medtronic Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 increased by 0.4% to $1.15B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 47.1%, from $784.00M to $1.15B.
A shift toward this bucket suggests a strategy focused on locking in longer-term yields.
This represents the amortized cost of debt securities in the available-for-sale portfolio that have maturity dates betwe...
Standard maturity bucket reporting for insurance investment portfolios.
other_available_for_sale_securities_debt_maturities_afte_0f7586| Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|
| Value | $685.00M | $750.00M | $784.00M | $1.11B | $1.15B | $1.15B |
| QoQ Change | — | +9.5% | +4.5% | +40.9% | +3.9% | +0.4% |
| YoY Change | — | — | — | +61.3% | +53.1% | +47.1% |